Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SCX Stock Summary
Top 10 Correlated ETFs
SCX
In the News
6 Deep Value Microcaps With Decent Trading Momentum
With the overall U.S. stock market struggling for direction, stock picking is now of paramount importance. Little-followed microcaps offer an area where bargains can be found.
The Starrett Company Is Selling At A Discount Because Of Its Underfunded Pension Plan
SCX manufactures a gigantic array of tools that are sold to several industries and to consumers.
The L.S. Starrett Company: Strong Upside Is Still On The Table
Recent performance, from a share price perspective, for investors in The L.S. Starrett Company has been disappointing.
SA Interview: Deep Value Investing In Microcap And Small Cap Stocks With Jeremy Blum
Jeremy Blum is primarily a microcap and small cap investor of deep value stocks though he casts a wide net. He has a specialty in turnaround situations. Investing in turnarounds (and what to look for), why looking at the balance sheet is key for deep value stocks and how to gain an edge with independent earnings estimates are topics discussed.
L.S. Starrett Doubled As Predicted And May Double Again
L.S. Starrett is a microcap tool manufacturer that has rallied on strong and accelerating earnings over the past four quarters. Yet it still trades at a PE ratio of about 6.
The L.S. Starrett Company Announces Fiscal 2021 Results
ATHOL, Mass.--(BUSINESS WIRE)--The L.S. Starrett Company (NYSE: SCX) (“Starrett” or “the Company,”) a global innovator, manufacturer and marketer of precision measuring tools, cutting tools and equipment, and high-end metrology solutions for industrial, professional, and consumer markets, today announced operating results for the fiscal year ended June 30, 2021. Sales and order intake return to pre-pandemic levels Sales and order intake trends began to improve in the second quarter of fiscal 20
The L.S. Starrett Company in Compliance with NYSE Continued Listing Standards
ATHOL, Mass.--(BUSINESS WIRE)--The L. S. Starrett Company (NYSE: SCX) (Starrett or the Company), a leading manufacturer of high-end precision tools, cutting equipment, and metrology systems for industrial, professional and consumer markets, today announced that on March 4, the NYSE notified the Company it has returned to compliance in relation to the NYSE's quantitative continued listing standards. This decision comes as a result of the Company's achievement of compliance with the NYSE's minimu
L.S. Starrett Is One Of The Last Microcaps Left Behind; It Should Double
L.S. Starrett is a microcap tool manufacturer that rallied some on good earnings last month. Rapidly improving earnings and revenue and a PE ratio of 6 indicate it is still way undervalued.
Where Do Hedge Funds Stand On The L.S. Starrett Company (SCX)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don't always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let's take a look at the recent hedge fund activity surrounding The L.S. Starrett Company (NYSE:SCX).
SCX Financial details
SCX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 32.78 | 28.99 | 31.07 | 35.11 | 34.66 | |
Net income per share | 0.87 | -3.14 | 2.2 | 2.06 | 3.12 | |
Operating cash flow per share | 1.21 | -0.17 | 0.65 | 0.73 | 3.39 | |
Free cash flow per share | 0.17 | -1.69 | -0.16 | -0.51 | 2.31 | |
Cash per share | 2.24 | 1.94 | 1.29 | 2.01 | 1.41 | |
Book value per share | 11.98 | 6.62 | 11.82 | 14.18 | 17.52 | |
Tangible book value per share | 10.1 | 5.75 | 10.98 | 13.39 | 16.75 | |
Share holders equity per share | 11.98 | 6.62 | 11.82 | 14.18 | 17.52 | |
Interest debt per share | 3.25 | 5.24 | 3.87 | 5.32 | 2.27 | |
Market cap | 47.97M | 23.56M | 66.03M | 50.73M | 77.24M | |
Enterprise value | 53.99M | 45.53M | 83.28M | 73.35M | 82.13M | |
P/E ratio | 7.89 | -1.08 | 4.25 | 3.41 | 3.35 | |
Price to sales ratio | 0.21 | 0.12 | 0.3 | 0.2 | 0.3 | |
POCF ratio | 5.71 | -20.26 | 14.46 | 9.59 | 3.08 | |
PFCF ratio | 41 | -2 | -57.98 | -13.65 | 4.52 | |
P/B Ratio | 0.58 | 0.51 | 0.79 | 0.5 | 0.6 | |
PTB ratio | 0.58 | 0.51 | 0.79 | 0.5 | 0.6 | |
EV to sales | 0.24 | 0.23 | 0.38 | 0.29 | 0.32 | |
Enterprise value over EBITDA | 2.94 | -11.7 | 3.16 | 2.43 | 2.33 | |
EV to operating cash flow | 6.43 | -39.15 | 18.23 | 13.86 | 3.27 | |
EV to free cash flow | 46.15 | -3.87 | -73.12 | -19.74 | 4.81 | |
Earnings yield | 0.13 | -0.93 | 0.24 | 0.29 | 0.3 | |
Free cash flow yield | 0.02 | -0.5 | -0.02 | -0.07 | 0.22 | |
Debt to equity | 0.26 | 0.77 | 0.32 | 0.36 | 0.12 | |
Debt to assets | 0.11 | 0.21 | 0.14 | 0.19 | 0.08 | |
Net debt to EBITDA | 0.33 | -5.65 | 0.66 | 0.75 | 0.14 | |
Current ratio | 3.67 | 3.74 | 2.31 | 3.23 | 3.09 | |
Interest coverage | 11.5 | 5.56 | 16.58 | 17.04 | 13.43 | |
Income quality | 1.38 | 0.05 | 0.29 | 0.36 | 1.09 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.32 | |
Payout ratio | 0 | 0 | 0 | 0 | 1.08 | |
Sales general and administrative to revenue | 0.28 | 0.3 | 0.24 | 0.23 | 0.23 | |
Research and developement to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.07 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.86 | 9.11 | -1.25 | -1.7 | -0.32 | |
Capex to revenue | -0.03 | -0.05 | -0.03 | -0.04 | -0.03 | |
Capex to depreciation | -0.98 | -1.47 | -0.91 | -1.36 | -1.24 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.35 | 21.63 | 24.17 | 25.63 | 35.09 | |
ROIC | 0.07 | 0.07 | 0.13 | 0.1 | 0.11 | |
Return on tangible assets | 0.03 | -0.13 | 0.09 | 0.08 | 0.12 | |
Graham Net | -4.78 | -9.35 | -4.99 | -2.34 | 0.99 | |
Working capital | 87.3M | 76.26M | 67.53M | 91.87M | 82.64M | |
Tangible asset value | 70.25M | 39.97M | 77.63M | 96.77M | 123.78M | |
Net current asset value | 13.27M | -22.6M | 18.27M | 35.93M | 58.87M | |
Invested capital | 0.26 | 0.77 | 0.32 | 0.36 | 0.12 | |
Average receivables | 34.53M | 32.5M | 32.04M | 39.02M | 39.79M | |
Average payables | 11.36M | 10.23M | 12.4M | 15.93M | 14.84M | |
Average inventory | 59.91M | 57.39M | 56.78M | 63.74M | 66.16M | |
Days sales outstanding | 57.59 | 52.57 | 58.29 | 61.81 | 52.16 | |
Days payables outstanding | 30.71 | 19.87 | 42.98 | 31.5 | 31.62 | |
Days of inventory on hand | 147.33 | 138.9 | 151.12 | 144.1 | 137.46 | |
Receivables turnover | 6.34 | 6.94 | 6.26 | 5.91 | 7 | |
Payables turnover | 11.88 | 18.37 | 8.49 | 11.59 | 11.54 | |
Inventory turnover | 2.48 | 2.63 | 2.42 | 2.53 | 2.66 | |
ROE | 0.07 | -0.47 | 0.19 | 0.15 | 0.18 | |
Capex per share | -1.04 | -1.53 | -0.81 | -1.25 | -1.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.02 | 8.3 | 9.05 | 8.15 | 8.28 | |
Net income per share | 0.42 | 1.01 | 1.4 | 0.26 | -0.05 | |
Operating cash flow per share | 0.52 | 1.54 | 1.24 | 0.65 | 0.31 | |
Free cash flow per share | 0.11 | 1.34 | 0.92 | 0.18 | -0.43 | |
Cash per share | 1.21 | 1.16 | 1.41 | 1.68 | 0.76 | |
Book value per share | 14.57 | 15.76 | 17.42 | 17.34 | 17.48 | |
Tangible book value per share | 13.84 | 15.01 | 16.66 | 16.57 | 16.7 | |
Share holders equity per share | 14.57 | 15.76 | 17.42 | 17.34 | 17.48 | |
Interest debt per share | 4.05 | 2.88 | 2.05 | 2.42 | 1.61 | |
Market cap | 54.5M | 83.33M | 77.64M | 79.95M | 90.76M | |
Enterprise value | 76.67M | 95.51M | 82.54M | 85.41M | 97.15M | |
P/E ratio | 4.35 | 2.79 | 1.86 | 10.41 | -57.59 | |
Price to sales ratio | 0.82 | 1.35 | 1.15 | 1.32 | 1.46 | |
POCF ratio | 14.17 | 7.3 | 8.46 | 16.59 | 39.58 | |
PFCF ratio | 66.63 | 8.35 | 11.39 | 61.22 | -28.42 | |
P/B Ratio | 0.51 | 0.71 | 0.6 | 0.62 | 0.69 | |
PTB ratio | 0.51 | 0.71 | 0.6 | 0.62 | 0.69 | |
EV to sales | 1.15 | 1.55 | 1.23 | 1.41 | 1.57 | |
Enterprise value over EBITDA | 9.93 | 16.78 | 5.11 | 20.85 | 23.35 | |
EV to operating cash flow | 19.93 | 8.36 | 8.99 | 17.73 | 42.37 | |
EV to free cash flow | 93.73 | 9.58 | 12.1 | 65.4 | -30.42 | |
Earnings yield | 0.06 | 0.09 | 0.13 | 0.02 | 0 | |
Free cash flow yield | 0.02 | 0.12 | 0.09 | 0.02 | -0.04 | |
Debt to equity | 0.29 | 0.18 | 0.12 | 0.14 | 0.09 | |
Debt to assets | 0.16 | 0.11 | 0.08 | 0.09 | 0.06 | |
Net debt to EBITDA | 2.87 | 2.14 | 0.3 | 1.33 | 1.54 | |
Current ratio | 3.59 | 3.26 | 3.09 | 2.94 | 3.11 | |
Interest coverage | -5.14 | 6.83 | -43.06 | 0 | 0 | |
Income quality | 1.23 | 1.53 | 0.88 | 2.51 | -5.81 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | -0.1 | |
Sales general and administrative to revenue | 0 | 0 | 0.19 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0.06 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.79 | -0.13 | -0.26 | -0.73 | -2.39 | |
Capex to revenue | -0.05 | -0.02 | -0.04 | -0.06 | -0.09 | |
Capex to depreciation | -1.83 | -0.92 | -1.52 | -2.15 | -3.29 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.77 | 18.89 | 23.46 | 10.04 | 4.55 | |
ROIC | 0.03 | 0.06 | 0.02 | 0.01 | 0 | |
Return on tangible assets | 0.02 | 0.04 | 0.06 | 0.01 | 0 | |
Graham Net | -1.7 | -0.97 | 0.98 | 0.56 | 0.87 | |
Working capital | 91.59M | 84.97M | 82.64M | 80.51M | 76.48M | |
Tangible asset value | 102.46M | 111.49M | 123.78M | 123.22M | 125.3M | |
Net current asset value | 41.72M | 45.81M | 58.87M | 55.24M | 56.81M | |
Invested capital | 0.29 | 0.18 | 0.12 | 0.14 | 0.09 | |
Average receivables | 38.11M | 37.21M | 36.44M | 35.56M | 34.67M | |
Average payables | 14.38M | 14.01M | 15.03M | 15.82M | 15.04M | |
Average inventory | 70.09M | 68.89M | 66.55M | 65.27M | 63.21M | |
Days sales outstanding | 51.42 | 52.92 | 48.98 | 51.22 | 50.49 | |
Days payables outstanding | 25.92 | 31.81 | 29.58 | 36.32 | 28.16 | |
Days of inventory on hand | 139.56 | 143.48 | 128.6 | 142.61 | 127.94 | |
Receivables turnover | 1.75 | 1.7 | 1.84 | 1.76 | 1.78 | |
Payables turnover | 3.47 | 2.83 | 3.04 | 2.48 | 3.2 | |
Inventory turnover | 0.64 | 0.63 | 0.7 | 0.63 | 0.7 | |
ROE | 0.03 | 0.06 | 0.08 | 0.01 | 0 | |
Capex per share | -0.41 | -0.2 | -0.32 | -0.47 | -0.73 |
SCX Frequently Asked Questions
What is The L.S. Starrett Company stock symbol ?
The L.S. Starrett Company is a US stock , located in Athol of Ma and trading under the symbol SCX
What is The L.S. Starrett Company stock quote today ?
The L.S. Starrett Company stock price is $15.9 today.
Is The L.S. Starrett Company stock public?
Yes, The L.S. Starrett Company is a publicly traded company.